CLINICAL_TRIALS
research
· 2026-03-13
Clinical Trial Update: Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH) [Phase 2]
Summary
A Phase 2 clinical trial evaluating CS060380 tablets for Non-alcoholic steatohepatitis (NASH) is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cascade Pharmaceuticals, Inc | Conditions: NASH | Phase 2 | Status: RECRUITING